yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q36032533-34CEC068-6304-4227-8EB4-6A3874EBE3D4
Q36032533-34CEC068-6304-4227-8EB4-6A3874EBE3D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36032533-34CEC068-6304-4227-8EB4-6A3874EBE3D4
Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma.
P2860
Q36032533-34CEC068-6304-4227-8EB4-6A3874EBE3D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36032533-34CEC068-6304-4227-8EB4-6A3874EBE3D4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5d573831e002ab29292f883aaef99cd13c8def73
P2860
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).